Biliopancreatic disorder
Conditions
Interventions
Sponsors
Hiroshima University hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patient over age 20 2. Patient who is clinically indicated for ERCP for examination or treatment of biliopancreatic disorder 3. Patient who has agreed to conditions after receiving an explanation about the contents of the present clinical study and who has signed the consent form
Exclusion criteria
Exclusion criteria: 1. Patients who have decompensated liver cirrhosis 2. Patients with severe renal dysfunction 3. Patients with severe cardiovascular disorder 4. Patients with severe respitatory disorder 5. Patients with severe neuro-muscular disorder 6. Patients who have experienced a serious adverse effect by midazolam 7. Patient with known contraindications for midazolam 8. Pregnant or potentially pregnant women 9. Other patients who are in the opinion of the caring investigator unfit for enrollment in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| measure of suffering of the patient after ERCP | — |
Countries
Japan
Contacts
Public ContactTomoyuki Minami
Hiroshima University hospital Department og gastroenterology and metabolism
Outcome results
None listed